HAT (Hemorrhage After Thrombolysis) Score for Predicting Post-tPA Hemorrhage
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–0
- Low-Moderate Risk1–1
- Moderate Risk2–2
- High Risk3–3
The HAT (Hemorrhage After Thrombolysis) Score for Predicting Post-tPA Hemorrhage calculates predicting hemorrhage risk after tPA administration in acute ischemic stroke patients. Key inputs include diabetes or glucose. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Predicts hemorrhage risk after tPA administration in acute ischemic stroke patients. Helps determine risk/benefit of tPA in borderline cases and identify patients needing closest monitoring.
Clinical Indication
The HAT (Hemorrhage After Thrombolysis) Score for Predicting Post-tPA Hemorrhage is indicated for bedside clinical practice to support Predicts hemorrhage risk after tPA administration in acute ischemic stroke patients. Helps determine risk/benefit of tPA in borderline cases and identify patients needing closest monitoring.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.
Limitations & Contraindications
Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.
Clinical Pearls & Action Plan
Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility.
HAT Score = Diabetes/Glucose (0-1) + NIHSS Score (0-2) + CT Hypodensity (0-2)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| diabetes_or_glucose | string | Yes | History of diabetes mellitus OR initial blood glucose >200 mg/dL (>11.1 mmol/L) |
| nihss_score | string | Yes | Pre-tPA NIH Stroke Scale score |
| hypodensity_on_ct | string | Yes | Easily visible hypodensity on initial head CT |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Low Risk | Low hemorrhage risk |
| 1–1 | Low-Moderate Risk | Low-moderate hemorrhage risk |
| 2–2 | Moderate Risk | Moderate hemorrhage risk |
| 3–3 | High Risk | High hemorrhage risk |
| 4–5 | Very High Risk | Very high hemorrhage risk |
Evidence-Based References (EBM)
- Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008 Oct 28;71(18):1417-23. doi: 10.1212/01.wnl.0000330297.58334.dd.DOI: 10.1212/01.wnl.0000330297.58334.dd
- Tsivgoulis G, Frey JL, Flaster M, Sharma VK, Lao AY, Hoover SL, et al. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage. Stroke. 2009 Nov;40(11):3631-4. doi: 10.1161/STROKEAHA.109.564096.DOI: 10.1161/STROKEAHA.109.564096
- Cucchiara B, Kasner SE, Tanne D, Levine SR, Demchuk A, Messe SR, et al. Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage. Int J Stroke. 2011 Apr;6(2):109-11. doi: 10.1111/j.1747-4949.2010.00555.x.DOI: 10.1111/j.1747-4949.2010.00555.x